Aptevo Therapeutics (APVO) Enterprise Value: -3.091M

Aptevo Therapeutics, Inc. (APVO)

1.77 +0.01 (+0.57%) USD | NASDAQ | Oct 05, 10:27

Enterprise Value Chart

Historical Enterprise Value Data

View and export this data back to 2016. Start Trial.

Date	Value
October 02, 2026	-3.091M
October 01, 2026	-3.091M
September 30, 2026	-3.005M
September 29, 2026	-2.949M
September 28, 2026	-2.878M
September 25, 2026	-2.906M
September 24, 2026	-2.991M
September 23, 2026	-2.906M
September 22, 2026	-2.963M
September 21, 2026	-3.020M
September 18, 2026	-2.977M
September 17, 2026	-2.977M
September 16, 2026	-3.147M
September 15, 2026	-3.162M
September 14, 2026	-3.034M
September 11, 2026	-3.005M
September 10, 2026	-2.991M
September 09, 2026	-2.970M
September 08, 2026	-2.920M
September 04, 2026	-3.119M
September 03, 2026	-3.162M
September 02, 2026	-1.899M
September 01, 2026	-2.268M
August 31, 2026	-2.126M
August 28, 2026	-2.232M

Date	Value
August 27, 2026	-2.154M
August 26, 2026	-2.168M
August 25, 2026	-2.097M
August 24, 2026	-2.168M
August 21, 2026	-1.785M
August 20, 2026	-1.672M
August 19, 2026	-1.714M
August 18, 2026	-1.473M
August 17, 2026	-1.601M
August 14, 2026	-1.416M
August 13, 2026	-0.7634M
August 12, 2026	-0.6215M
August 11, 2026	0.281M
August 10, 2026	0.1164M
August 07, 2026	0.3434M
August 06, 2026	0.1873M
August 05, 2026	0.3576M
August 04, 2026	0.2157M
August 03, 2026	0.017M
July 31, 2026	0.2441M
July 30, 2026	0.2725M
July 29, 2026	0.0596M
July 28, 2026	0.386M
July 27, 2026	0.386M
July 24, 2026	0.6414M

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks